Earnings Release • Nov 15, 2018
Earnings Release
Open in ViewerOpens in native device viewer

NESS ZIONA, Israel — November 15, 2018 — Foresight Autonomous Holdings Ltd., an innovator in automotive vision systems (Nasdaq and TASE: FRSX), today reported financial results for the third quarter ended September 30, 2018. Foresight ended the third quarter of 2018 with \$19.3 million in cash and short-term deposits, GAAP net loss of \$3.75 million and non-GAAP net loss for the same period of \$3.76 million.
"During the third quarter, we continued early sales of our QuadSight prototype and expanded our geographic footprint into Asia," commented Haim Siboni, CEO of Foresight. "We are pleased that a leading Chinese electric and autonomous vehicle manufacturer has recently purchased our QuadSight prototype. China is a market leader in electric vehicle sales, so the opportunity to test and potentially integrate our system opens the door to substantial future possibilities for revenue growth. Furthermore, additional customer relationships enable us to modify and improve our system based on market needs, improving our competitive edge."
● Research and development (R&D) expenses for the three months ended September 30, 2018 were \$2,217,000 compared to \$1,144,000 in the three months ended September 30, 2017. The increase is attributed mainly to accelerated employee recruitment and is comprised primarily of payroll and related expenses, stock-based compensation expenses and subcontracted service expenses.
● General and administrative (G&A) expenses for the three months ended September 30, 2018 were \$872,000 compared to \$684,000 in the three months ended September 30, 2018. The increase is attributed primarily to payroll and related expenses, and subcontracted service expenses.
● GAAP net loss for the three months ended September 30, 2018 was \$3,758,000, or \$0.03 loss per ordinary share, compared to a GAAP net profit of \$4,466,000, or \$0.04 profit per ordinary share, in the three months ended September 30, 2017. The change is attributed mainly to the revaluation of derivative warrant liability.
● Non-GAAP net loss for the three months ended September 30, 2018 was \$3,759,000, or \$0.03 loss per ordinary share, compared to a non-GAAP net loss of \$2,086,000, or \$0.02 loss per ordinary share, in the three months ended September 30, 2017. A reconciliation between GAAP net loss and non-GAAP net loss is provided in the financial statements that are part of this release. Non-GAAP results exclude the effect of stock-based compensation expenses, revaluation of other investments and revaluation of derivative warrant liability.
| As of September 30, |
As of December 31, |
||||
|---|---|---|---|---|---|
| (thousands of U.S. dollars) | 2018 | 2017 | 2017 | ||
| GAAP Results | |||||
| Shareholders' equity | \$ 32,562 | \$ 15,598 | \$ 24,817 | ||
| Non-GAAP Results | |||||
| Shareholders' equity | \$ 27,312 | \$ 21,890 | \$ 22,921 |
A reconciliation between GAAP shareholders' equity results and non-GAAP shareholders' equity results is provided in the financial statements that are part of this release. Non-GAAP results exclude revaluation of other investments and derivative warrant liability.
In addition to disclosing financial results calculated in accordance with United States generally accepted accounting principles (GAAP), the company's earnings release contains non-GAAP financial measures of net loss for the period that excludes the effect of stock-based compensation expenses, the revaluation of other investments and revaluation of derivative warrant liability, and non-GAAP financial measures of shareholders' equity that excludes the effect of derivative warrant liability and the revaluation of other investments. The company's management believes the non-GAAP financial information provided in this release is useful to investors' understanding and assessment of the company's ongoing operations. Management also uses both GAAP and non-GAAP information in evaluating and operating business internally and as such deemed it important to provide all this information to investors. The non-GAAP financial measures disclosed by the company should not be considered in isolation or as a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. Reconciliations between GAAP measures and non-GAAP measures are provided later in this press release.
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry. Foresight's vision systems are based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. The company, through its wholly owned subsidiary Foresight Automotive Ltd., develops advanced systems for accident prevention which are designed to provide real-time information about the vehicle's surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. The company's systems are targeting the Advanced Driver Assistance Systems (ADAS), semiautonomous and autonomous vehicle markets. The company predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses future possibilities for revenue growth and potential revenues from prototype system sales. Because such statements deal with future events and are based on Foresight's current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Foresight's annual report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on March 27, 2018, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.
Miri Segal-Scharia CEO MS-IR LLC [email protected] 917-607-8654
| U.S. dollars in thousands | ||||||
|---|---|---|---|---|---|---|
| As of September 30, 2018 |
As of September 30, 2017 |
As of December 31, 2017 |
||||
| ASSETS | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | \$ | 11,172 | \$ 10,182 |
\$ | 9,636 | |
| Short term deposits | 8,109 | 11,342 | 12,169 | |||
| Marketable equity securities | 24 | 20 | 22 | |||
| Other investments | 5,574 | - | 2,361 | |||
| Other receivables | 526 | 369 | 482 | |||
| Total current assets | 25,405 | 21,913 | 24,670 | |||
| Non-current assets: | ||||||
| Investment in affiliate company | 7,559 | 522 | 1,404 | |||
| Other investments | - | 66 | 1,672 | |||
| Fixed assets, net | 827 | 186 | 289 | |||
| 8,386 | 774 | 3,365 | ||||
| Total assets | \$ | 33,791 | 22,687 | \$ | 28,035 | |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||
| Current liabilities: | ||||||
| Trade payables | \$ | 223 | 259 | \$ | 330 | |
| Other accounts payables | 928 | 538 | 817 | |||
| Derivative warrant liability | 2 | - | - | |||
| Total current liabilities | 1,153 | 797 | 1,147 | |||
| Derivative warrant liability | 76 | 6,292 | 2,071 | |||
| Total liabilities | 1,229 | 7,089 | 3,218 | |||
| Shareholders' equity: | ||||||
| Common shares of no par value; | - | - | - | |||
| Additional paid-in capital | 57,102 | 41,389 | 44,114 | |||
| Accumulated deficit | (24,540) | (25,791) | (19,297) | |||
| Total shareholders' equity | 32,562 | 15,598 | 24,817 | |||
| Total liabilities and shareholders' equity | \$ | 33,791 | 22,687 | \$ | 28,035 |
| U.S. dollars in thousands | ||||
|---|---|---|---|---|
| As of September 30, 2018 |
As of September 30, 2017 |
As of December 31, 2017 |
||
| GAAP Shareholders' equity | 32,562 | 15,598 | 24,817 | |
| Revaluation of other investments | (5,328) | - | (3,967) | |
| Derivative warrant liability | 78 | 6,292 | 2,071 | |
| Non-GAAP Shareholders' equity | 27,312 | 21,890 | 22,921 |
| Nine months ended September 30, |
Three months ended September 30, |
|||
|---|---|---|---|---|
| 2018 | 2017 | 2018 | 2017 | |
| Research and development expenses | (6,478) | (2,419) | (2,217) | (1,144) |
| Marketing and sales | (775) | (776) | (234) | (263) |
| General and administrative expenses | (2,813) | (3,021) | (872) | (684) |
| Operating loss | (10,066) | (6,216) | (3,323) | (2,091) |
| Equity in net loss of an affiliated company | (2,112) | (726) | (1,035) | (343) |
| Financing income (expenses), net | 6,935 | (15,494) | 600 | 6,900 |
| Net (loss) profit | (5,243) | (22,436) | (3,758) | 4,466 |
U.S. dollars in thousands
| Nine months ended September 30, |
Three months ended September 30, |
||||
|---|---|---|---|---|---|
| 2018 | 2017 | 2018 | 2017 | ||
| Net cash used in operating activities | |||||
| Profit (loss) for the period |
(5,243) | (22,436) | (3,758) | 4,466 | |
| Adjustments to reconcile profit (loss) to net cash | |||||
| used in operating activities: | (2,959) | 18,642 | 146 | (5,930) | |
| (8,202) | (3,794) | (3,612) | (1,464) | ||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities |
|||||
| Changes in short term deposits | 4,060 | (10,952) | 3,053 | (7,323) | |
| Investment in affiliate company | (4,479) | - | (1,990) | - | |
| Proceeds from sales of fixed assets | 1 | - | 1 | - | |
| Purchase of fixed assets | (712) | (149) | (282) | (69) | |
| Net cash provided (used) in investing activities |
(1,130) | (11,101) | 782 | (7,392) | |
| Cash flows from Financing Activities: | |||||
| Issuance of ordinary shares and warrants, net of | |||||
| issuance expenses | 11,208 | 10,745 | 5,403 | - | |
| Exercise of warrants and options, net of issuance |
|||||
| expenses | 159 | 10,646 | - | 5,050 | |
| Net cash provided by financing activities | 11,367 | 21,391 | 5,403 | 5,050 | |
| Effect of exchange rate changes on cash and | |||||
| cash equivalents | (499) | 322 | 116 | (294) | |
| Increase (decrease) in cash and cash | |||||
| equivalents | 1,536 | 6,818 | 2,689 | (4,100) | |
| Cash and cash equivalents at the beginning of | |||||
| the period | 9,636 | 3,364 | 8,483 | 14,282 | |
| Cash and cash equivalents at the end of the | |||||
| period | 11,172 | 10,182 | 11,172 | 10,182 |
U.S. dollars in thousands
| Nine months | Three months | ||||
|---|---|---|---|---|---|
| Adjustments to reconcile profit (loss) to net | ended | ended | |||
| cash used in operating activities: | September 30, | September 30, | |||
| 2018 | 2017 | 2018 | 2017 | ||
| Share-based payment | 1,620 | 2,063 | 440 | 424 | |
| Depreciation | 170 | 30 | 80 | 15 | |
| Loss from sale of fixed assets | 3 | 3 | |||
| Revaluation of derivative warrant liability | (1,993) | 16,074 | (441) | (6,976) | |
| Equity in loss of an affiliated company | 2,112 | 726 | 1,035 | 343 | |
| Revaluation of securities | (2) | (3) | 20 | 3 | |
| Revaluation of other investments | (5,328) | - | - | - | |
| exchange rate changes on cash and cash equivalents | 499 | (322) | (116) | 294 | |
| Changes in assets and liabilities: | |||||
| Decrease (increase) in other receivables | (44) | (266) | (186) | (89) | |
| Increase (decrease) in trade payables | (107) | 155 | (83) | 156 | |
| Increase (decrease) in other accounts payable | 111 | 185 | (606) | (100) | |
| Adjustments to reconcile profit (loss) to net | |||||
| cash used in operating activities | (2,959) | 18,642 | 146 | (5,930) | |
| Nine months ended September 30 |
Three months ended September 30, |
|||
|---|---|---|---|---|
| 2018 | 2017 | 2018 | 2017 | |
| GAAP operating loss | (10,066) | (6,216) | (3,323) | (2,091) |
| Stock-based compensation in research and | ||||
| development | 491 | 345 | 142 | 162 |
| Stock-based compensation in sales and marketing | 143 | 354 | 47 | 94 |
| Stock-based compensation in general and | ||||
| administrative | 986 | 1,364 | 251 | 168 |
| Non-GAAP operating loss | (8,446) | (4,153) | (2,883) | (1,667) |
| GAAP financing income (expenses), net | 6,935 | (15,494) | 600 | 6,900 |
| Revaluation of other investments | (5,328) | - | - | - |
| Revaluation of derivative warrant liability | (1,993) | 16,074 | (441) | (6,976) |
| Non-GAAP financing income (expenses), net | (386) | 580 | 159 | (76) |
| GAAP net profit (loss) | (5,243) | (22,436) | (3,758) | 4,466 |
| Stock-based compensation expenses | 1,620 | 2,063 | 440 | 424 |
| Revaluation of other investments | (5,328) | - | - | - |
| Revaluation of derivative warrant liability | (1,993) | 16,074 | (441) | 6,976 |
| Non-GAAP net loss | (10,944) | (4,299) | (3,759) | (2,086) |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.